Golden State Equity Partners Astrazeneca PLC Transaction History
Golden State Equity Partners
- $569 Million
- Q3 2025
A detailed history of Golden State Equity Partners transactions in Astrazeneca PLC stock. As of the latest transaction made, Golden State Equity Partners holds 7,895 shares of AZN stock, worth $705,813. This represents 0.11% of its overall portfolio holdings.
Number of Shares
7,895
Previous 7,040
12.14%
Holding current value
$705,813
Previous $491,000
23.22%
% of portfolio
0.11%
Previous 0.09%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,536Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...